H19 and thyroid gland carcinoma: Recent studies have shown that lncRNAs that interact with estrogen receptors, such as Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1), and lncRNA-H19 (H19), are enhanced by estrogen receptors in lung and thyroid cancers.